False
Thomas V. Johnson is a glaucoma specialist and faculty member at Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. He is a consultant for Abbvie, and receives research support from Alcon, InjectSense, iCare USA and Perfuse Therapeutics.
December 19, 2022
How do “transfers of value” influence your clinical decisions? Welcome to the TOV effect
9 min read
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False